Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.1.02242
European Journal of Endocrinology, Vol 155, Issue 3, 395-403
Copyright © 2006 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cawood, T J
Right arrow Articles by O’Shea, D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cawood, T J
Right arrow Articles by O’Shea, D

CLINICAL STUDY

The effects of tumour necrosis factor-{alpha} and interleukin1 on an in vitro model of thyroid-associated ophthalmopathy; contrasting effects on adipogenesis

T J Cawood1,2, P Moriarty3, C O’Farrelly2,4 and D O’Shea1

1 Department of Endocrinology, and 2 Education and Research Centre, Saint Vincent’s University Hospital, Dublin, Ireland, 3 Royal Victoria Eye and Ear Hospital, Dublin, Ireland and 4 The Conway Institute, University College Dublin, Dublin, Ireland

(Correspondence should be addressed to T J Cawood; Email: tomjcawood{at}eircom.net)

Objective: Cytokines are likely to play a key pathogenic role in thyroid-associated ophthalmopathy (TAO). Anti-cytokine therapy has been proposed to be a possible treatment for active TAO. We aimed to establish the effects of selected cytokines on intercellular adhesion molecule 1 (ICAM1) expression, glycosaminoglycan (GAG) production and adipogenesis in orbital fibroblasts (OFs) from patients with TAO.

Methods: Orbital tissue was taken during surgery from eight patients with TAO and five control subjects. OFs were cultured and ICAM1 expression measured by flow cytometry. GAG production was measured by hyaluronic acid ELISA. OFs were grown in adipogenic media and the degree of adipogenesis quantified.

Results: Responses were similar in OFs from patients with and without TAO. Tumour necrosis factor-{alpha} (TNF{alpha}) and interleukin1 (IL1) (0.1 ng/ml) stimulated ICAM1 expression by eight- to ten-fold. Anti-cytokine agents inhibited the cytokine-upregulated ICAM1 expression by 90–99% (P<0.01). TNF{alpha} and IL1 (0.1 ng/ml) increased hyaluronic acid production by 44 and 95% (P<0.01) respectively. Anti-cytokine agents inhibited these responses by 79–138% (P<0.04). TNF{alpha} (0.1 ng/ml) inhibited adipogenesis (–0.013 AU and –1.0; P<0.03) whilst IL1 (0.1 ng/ml) stimulated adipogenesis (+0.05 AU and +5.7; P<0.02) measured by oil-red-O extraction and visual assessment respectively. The anti-IL1 agent inhibited IL1-mediated adipogenesis by 69–106% (P<0.04).

Conclusion: TNF{alpha} and IL1 stimulate ICAM1 expression and GAG production, but have opposite effects on adipogenesis in OFs in vitro. IL1 promotes adipogenesis and its effects can be blocked by anti-IL1 agents in vitro. These agents may be the anti-cytokine treatment of choice for clinical trials in active TAO.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
T. J. Cawood, P. Moriarty, C. O'Farrelly, and D. O'Shea
Smoking and Thyroid-Associated Ophthalmopathy: A Novel Explanation of the Biological Link
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 59 - 64.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 European Society of Endocrinology.